In order to make sure that you are using credible sources if and when you want to do some drug injury research, there is an FDA information site and an FDA database that is searchable which we want you to know are available online. (1) Drug Safety Communications This webpage was developed to provide the public with easy access to important drug … [Read more...]
BIA-ALCL Current Recommendations and Potential Future FDA Guidance Changes
History of BIA-ALCL In 2011, the Food and Drug Administration (FDA) reported 34 cases worldwide of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), bringing this unique disease into the public eye for the first time. Since then, BIA-ALCL has been recognized internationally as a distinct type of cancer, and prompted the 2019 … [Read more...]
FDA Proposes New Recommendations for Breast Implant Labels
The FDA has come up with a draft guidance list of labeling changes that they recommend be made by breast implant manufacturers to address the safety concerns threatening women all over the world. The recent October 2019 article from The New York Times, “Women Should Be Warned of Breast Implant Hazards, F.D.A. Says”, tells us that “Agency officials … [Read more...]
Breast Implants FDA March 2019 Meeting: Lymphoma Cancer Was A Main Topic
There was an FDA CDRH General and Plastic Surgery Devices Advisory Committee Meeting held on March 25-26, 2019. The first day was focused in large part on Breast Implant Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL). This lymphoma cancer associated with breast implants is a rare type of blood cancer that is classified as a non-Hodgkin … [Read more...]
New Data Released on Risk of Lymphoma Due to Breast Implants
Recent Study on BIA-ALCL RisksSince my last article on this topic, "What is the Risk of Death Due to Breast Implant-Associated Lymphoma?," additional information on the risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been released. The most recent study, titled "Breast Implants and the Risk of Anaplastic Large-Cell … [Read more...]
Breast Implant-Associated Lymphoma Diagnoses on the Rise
On October 18, 2017, the JAMA Surgery journal published an article titled "Breast Implant–Associated Anaplastic Large Cell Lymphoma A Systematic Review," in which they discuss the rate of occurrence of the condition. The article served as a review of 115 articles on the topic of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) … [Read more...]
Breast Implants and Lymphoma: Who’s to Blame?
As previously discussed in my articles, "Breast Implants Linked to Rare Lymphoma Blood Cancer" and "Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable, the FDA recently updated their 2011 report of the association between breast implants and anaplastic large-cell lymphoma (ALCL), providing additional information on this rare form of … [Read more...]
Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable
As news of the possible link between breast implants and a rare form of lymphoma cancer has spread, more theories about how it develops have come to light. One such theory is outlined in the excerpt, below, from the article, "Increase in Australian cancer cases linked to breast implants": Dr. Gazi Hussain, Vice President of the Australian … [Read more...]
Breast Implants Linked to Rare Lymphoma Blood Cancer
The FDA first identified a possible link between breast implants and anaplastic large cell lymphoma (ALCL) in their report from January 2011. ALCL is a rare type of blood cancer that is classified as a non-Hodgkin lymphoma, and one of the subtypes of T-cell lymphoma. It can initially appear either in the skin, in the lymph nodes, or in organs … [Read more...]